Latest Security News

Aeris Resources reported solid FY25 results within guidance and secured $80 million in new equity to fund exploration and development projects, positioning itself for significant growth in FY26.

Ryman Healthcare has completed a full refinancing of its $2 billion syndicated loan facilities, extending the average maturity to five years and enhancing funding flexibility. The move aligns with the company’s disciplined growth strategy and sets the stage for future capital management decisions.

The a2 Milk Company has secured key regulatory approvals in China, moving closer to launching its infant formula products under the a2MC brand by mid-2027.

Gentrack Group reported robust FY25 results with an 8% revenue rise to NZ$230.2m and a 119% jump in net profit, driven by strong growth in utilities and airports segments alongside strategic investments in its new cloud platform and global expansion.

Gentrack Group reported a strong FY25 with revenue up 8% and net profit more than doubling, driven by key deployments of its new g2.0 cloud platform and robust growth in its airports division Veovo.

Sunshine Metals Limited will lift its trading suspension on 24 November 2025 following a key Supreme Court ruling. Investors await details on the court outcome that triggered the suspension.

Atomic Eagle Ltd, formerly known as Tombador Iron Limited, will have its trading suspension lifted and be reinstated to quotation on the ASX starting 24 November 2025 after meeting key compliance requirements.

Infomedia Ltd shares will halt trading following the Supreme Court of NSW's approval of a takeover scheme by a TPG Capital-backed entity. This marks a pivotal moment for the software company as it transitions to private ownership.

Aurumin Limited’s shares will be suspended from trading following court approval of Brightstar Resources’ acquisition scheme, marking a pivotal step in the takeover process.

WAM Income Maximiser Limited has confirmed its fully franked ordinary dividend for November 2025 and updated the Dividend Reinvestment Plan price, providing clarity for investors ahead of the payment date.

The Foreign Investment Review Board has formally objected to Cosette Pharmaceuticals’ proposed acquisition of Mayne Pharma, casting serious doubt on the deal’s future and prompting Mayne to explore alternative paths.

Equity Story Group Ltd has secured $1.2 million through a fully subscribed two-tranche placement to accelerate growth in its fund management business and prepare for entry into the property sector in 2026.